|
1.
|
National Kidney Foundation: DOQI kidney
diease outcome quality initiative. Am J Kidney Dis. 39:S1–S266.
2012.
|
|
2.
|
Bellomo R, Mårtensson J, Lo S, Kaukonen
KM, Cass A and Gallagher M: RENAL study investigators and the
Australian and New Zealand Intensive Care Clinical Trials Group:
Femoral access and delivery of continuous renal replacement therapy
dose. Blood Purif. 41:11–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Walker AM, Schneider G, Yeaw J, Nordstrom
B, Robbins S and Pettitt D: Anemia as a predictor of cardiovascular
events in patients with elevated serum creatinine. J Am Soc
Nephrol. 17:2293–2298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Phillips JK, Boyd R, Krockenberger MB and
Burgio G: Progression of anemia and its relationship with renal
function, blood pressure, and erythropoietin in rats with chronic
kidney disease. Vet Clin Pathol. 44:342–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Miret S, Tascioglu S, van der Burg M,
Frenken L and Klaffke W: In vitro bioavailability of iron from the
heme analogue sodium iron chlorophyllin. J Agric Food Chem.
58:1327–1332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yamamoto T, Miyazaki M, Nakayama M, Yamada
G, Matsushima M, Sato M, Sato T, Taguma Y, Sato H and Ito S: Impact
of hemoglobin levels on renal and non-renal clinical outcomes
differs by chronic kidney disease stages: the Gonryo study. Clin
Exp Nephrol. Oct 30–2015.(Epub ahead of print). View Article : Google Scholar
|
|
7.
|
Kawahara K, Minakuchi J, Yokota N, Suekane
H, Tsuchida K and Kawashima S: Treatment of renal anaemia with
erythropoiesis-stimulating agents in predialysis chronic kidney
disease patients: haemoglobin profile during the 6 months before
initiation of dialysis. Nephrology (Carlton). 20(Suppl 4): 29–32.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lee DJ, Fragata J, Pestana JO, Draibe S,
Canziani ME, Cendoroglo M and Góes MÂ Jr: Erythropoietin resistance
in end-stage renal disease patient with gastric antral vascular
ectasia. J Bras Nefrol. 37:410–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Christie M, Peritt D, Torres RM, Randolph
TW and Carpenter JF: The role of protein excipient in driving
antibody responses to erythropoietin. J Pharm Sci. 104:4041–4055.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wright DG, Wright EC, Narva AS, Noguchi CT
and Eggers PW: Association of erythropoietin dose and route of
administration with clinical outcomes for patients on hemodialysis
in the United States. Clin J Am Soc Nephrol. 10:1822–1830. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Liu X, Chen K, Shi H, Cai H, Li L, Lou J
and Qian B: Effect of sodium iron chlorophyllin (SIC) on CFU-E and
CFU-GM yields of normal and anemic animal models. Zhonghua Xue Ye
Xue Za Zhi. 18:234–236. 1997.(In Chinese). PubMed/NCBI
|
|
12.
|
Yin LM, Jiang HF, Wang X, Qian XD, Gao RL,
Lin XJ, Chen XH and Wang LC: Effects of sodium copper chlorophyllin
on mesenchymal stem cell function in aplastic anemia mice. Chin J
Integr Med. 19:360–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Suryavanshi S, Sharma D, Checker R, Thoh
M, Gota V, Sandur SK and Sainis KB: Amelioration of
radiation-induced hematopoietic syndrome by an antioxidant
chlorophyllin through increased stem cell activity and modulation
of hematopoiesis. Free Radic Biol Med. 85:56–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ouameur AA, Marty R and Tajmir-Riahi HA:
Human serum albumin complexes with chlorophyll and chlorophyllin.
Biopolymers. 77:129–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ferruzzi MG, Failla ML and Schwartz SJ:
Sodium copper chlorophyllin: in vitro digestive stability and
accumulation by Caco-2 human intestinal cells. J Agric Food Chem.
50:2173–2179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Witowski J, Kawka E, Rudolf A and Jörres
A: New developments in peritoneal fibroblast biology: implications
for inflammation and fibrosis in peritoneal dialysis. BioMed Res
Int. 2015:1347082015. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Stępniewska J, Gołembiewska E, Dołęgowska
B, Domański M and Ciechanowski K: Oxidative stress and
antioxidative enzyme activities in chronic kidney disease and
different types of renal replacement therapy. Curr Protein Pept
Sci. 16:243–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Stępniewska J, Dołęgowska B, Popińska M,
Sałata D, Budkowska M, Gołembiewska E, Myślak M, Domański M,
Marchelek-Myśliwiec M and Ciechanowski K:
Prooxidative-antioxidative balance of cells in different types of
renal replacement therapy. Blood Purif. 37:4–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Padda RS, Shi Y, Lo CS, Zhang SL and Chan
JS: Angiotensin-(1–7): a novel peptide to treat hypertension and
nephropathy in diabetes? J Diabetes Metab. 6:1–6. 2015.
|
|
20.
|
Padda RS, Gkouvatsos K, Guido M, Mui J,
Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism
but does not promote liver fibrosis in hemochromatotic
Hjv−/− mice. Am J Physiol Gastrointest Liver Physiol.
308:G251–G261. 2015. View Article : Google Scholar : PubMed/NCBI
|
